Putting Carevive SMART Data to Work

Carevive SMART Data is making waves in the pharmaceutical industry as it gets licensed to companies looking to enhance their value chain. This revolutionary dataset is being utilized for crucial use cases, particularly in clinical trials.

Pharmaceutical companies are now leveraging SMART Data to precisely target the right patient populations and determine essential patient experience measures for inclusion in their clinical trials. By integrating this definitive set of Patient-Reported Outcomes (PROs) into new study designs, trials gain a valuable dimension that bolsters the quality of trial data and strengthens regulatory submissions.

We’re excited to discuss Carevive SMART Data with you in-depth, showcasing how it can transform your clinical trials and regulatory strategies. Together, let’s pave the way for more effective and patient-centered therapies in the ever-evolving landscape of cancer care.

Recent Episodes

Economic mobility is often portrayed as a straight climb. In reality, it’s shaped by adversity, identity, and access to opportunity. As research from the University of Michigan notes, mobility requires not only income, education, and employment, but also more intangible resources such as social inclusion and power—the ability to make choices and exert influence….

The U.S. healthcare system is strained by rising costs, uneven quality, and fragmented care navigation. Employers are bearing the brunt, spending more without always securing better care for their teams. According to the RAND Corporation, one effective strategy is to “change their network and benefit designs to encourage patients to use lower‑priced, higher‑value providers…

Generative AI has captured the public imagination, but its most transformative use cases may lie far from flashy consumer tools. In healthcare operations, where complexity, inefficiency, and fragmentation remain persistent challenges, AI is now driving measurable improvements. Research suggests AI-enabled healthcare systems could cut administrative costs by up to $360 billion in the U.S. alone….